期刊文献+

针对我国HIV-1流行株的AIDS疫苗研究策略与进展——国家传染病重大专项进展介绍

Strategy for the development of AIDS vaccine against Chinese HIV-1subtypes and recent progress--the introduction of the project supported by the National Science and Technology Key Project on Major Infectious Diseases
下载PDF
导出
摘要 虽然RV144 AIDS疫苗临床试验观察到了部分保护效果,但远未达到临床应用的要求,其保护水平有待进一步提高。鉴于抗体反应和T细胞反应在抵抗和控制HIV-1感染过程中的重要作用,我们认为可以通过同时活化有效的抗体反应和T细胞反应来提升AIDS疫苗的保护效果。在国家传染病重大专项课题的资助下,本实验室设计了一套针对我国HIV-1流行株的AIDS疫苗策略,本文简要介绍我们的设计方案及主要研究进展。 Ahhough tile RV144 trial reported an AIDS vaccine regimen confen'ed certain protection against HIV acquisition, tile vaeeine is far from being used in clinical practice for the low protection rate. Since both humoral and cellular immune responses play important roles in inhibiting and controlling HIV-1 infection, we believe tile efficacy of AIDS vaccine can be further improved if the two arms of adaptive immune systems can work synergistically. Supported by the National Science and Technology Key Project on Major Infectious Diseases, our laboratot7 designed a vaccine strategy against major circulating HIV-I subtypes in China. This review briefly introduces the rationale of our design and major achievements.
出处 《传染病信息》 2013年第4期202-204,258,共4页 Infectious Disease Information
基金 国家"十二五"科技重大专项(2012ZX10001-006 2013ZX10001002) 上海市自然科学基金(11ZR1430600) 上海市卫生局新百人计划(XBR2011042)
关键词 疫苗 获得性免疫缺陷综合征 HIV-1 vaccines acquired immunodeficiency syndrome HIV-1
  • 相关文献

参考文献9

二级参考文献205

  • 1邢辉,梁浩,万卓越,陈曦,魏民,马鹏飞,关琪,全宇,洪坤学,邵一鸣.中国CRF01-AE亚型人类免疫缺陷病毒毒株的分子流行病学研究[J].中华预防医学杂志,2004,38(5):300-304. 被引量:59
  • 2安焕宇,范淑兰,安丽颖,韩亚儒,过琴媛.天花疫苗的规模化制备[J].中国生物制品学杂志,2006,19(5):497-498. 被引量:4
  • 3Cohen J. HIV/AIDS research. Surprising AIDS vaccine success praised and pondered[J]. Science, 2009, 326(5949):26- 27.
  • 4Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand[EB/OL]. [2009-10-22]. http://content.nejm. org/cgi/content/full/NEJMoa0908492.
  • 5Mulligan MJ. Advances in human clinical trials of vaccines to prevent HIV/AIDS and other HIV prevention interventions[J]. Curr Infect Dis Rep, 2009, 11(5):399-406.
  • 6Letvin NL. Progress toward an HIV vaccine[J]. Annu Rev Med, 2005, 56:213-223.
  • 7Baroneh DH. Challenges in the development of an HIV-1 vaccine[J]. Nature, 2008, 455(7213):613-619.
  • 8Hu SL. Non-human primate models for AIDS vaccine research[J]. Curr Drug Targets Infect Disord, 2005, 5(2): 193- 201.
  • 9Hatziioannou T, Ambrose Z, Chung NP, et al. A macaque model of HIV-1 infection[J]. Proc Natl Acad Sci U S A, 2009, 106(11):4425 -4429.
  • 10Berman PW, Gregory TJ, Riddle L, et al. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160[J]. Nature, 1990, 345(6276):622-625.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部